biotechScienceGene Editing Is Trickier Than Expected—but Fixes Are in SightBy Megan MolteniThe Big StoryMonkeys With Superpower Eyes Could Help Cure Color BlindnessBy Adam RogersScienceInside the Lab Training Genome Surgeons to Fight DiseaseBy Megan MolteniScienceThe Human Cell Atlas Is Biologists' Latest Grand ProjectBy Megan MolteniScienceCrispr’s Epic Patent Fight Changed the Course of BiologyBy Megan MolteniScienceCrispr Halted Muscular Dystrophy in Dogs. Are Humans Next?By Megan MolteniScienceWith Embryo Base Editing, China Gets Another Crispr FirstBy Megan MolteniScienceInside a Chemist’s Quest to Cure Genetic DiseaseBy Megan MolteniScienceCrispr Fans Fight for Egalitarian Access to Gene EditingBy Megan MolteniScienceBiopunks are Pushing the Limits With Implants and DIY DrugsBy Caitlin HarringtonScienceSaving Grace: The Race to Cure a Daughter’s Genetic DiseaseBy Erika Check HaydenScienceWhat Good Is Crispr if It Can't Get Where It Needs to Go?By Megan MolteniScienceWhy Biotech Is Clashing over the Future of Gene TherapyBy Megan MolteniScienceCrispr Isn’t Enough Any More. Get Ready for Gene Editing 2.0By Megan MolteniOpinionA Radical Proposal For Preventing Rare Genetic DiseasesBy Lee CooperThe Big StoryThese DNA Diet Apps Want to Rule Your HealthBy Alexandra OssolaScienceSure, Subways Are Gross. But Antibiotics Aren't the AnswerBy Megan MolteniScienceThe Chemical Industry's Having a Bad Reaction to New RegsBy Megan MolteniScienceTheranos Blew It. But It Didn't Ruin Biotech Startups for EveryoneBy Megan MolteniScienceA Magical Mushroom Powder Blocks Bitterness in FoodBy Megan MolteniScienceHot Tips For the Next Disruptive Blood Testing UnicornBy Nick StocktonThe Big Story“I Want to Know What Code Is Running Inside My Body”By K McGowanScienceY Combinator's Sam Altman Is Bullish on Biotech StartupsBy Sarah ZhangScienceBiotech's New Plan: Nobody Say 'GMO'By Sarah ZhangMore Stories
